EULAV Asset Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
EULAV Asset Management's AGN Position: Q3 2018 in Review
EULAV Asset Management sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 4,272 shares — an estimated $712K sold.
EULAV Asset Management first reported a position in AGN in Q2 2013 and held it in 20 quarters. The position peaked at $24.5M in Q4 2015. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.
- EULAV Asset Management reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
- EULAV Asset Management sold 4,272 Allergan plc shares in Q3 2018, an estimated $712K.
- EULAV Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 20 quarters.
- EULAV Asset Management's Allergan plc position peaked at $24.5M in Q4 2015.
- 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.
Based on EULAV Asset Management's 13F filing for Q3 2018, filed 26 Oct 2018.